RxDoctor Payments Data

Garrett Lovoy

Physician Assistant · Charleston, SCNPI 1841866035

Payments from drug & device makers

$722in general payments, 2019–2025

Across 22 payments — averaging $32.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$176
  • Sanofi$165
  • Regeneron Healthcare Solutions, Inc.$68
  • GSK$60
  • Genentech USA, Inc.$53
  • AstraZeneca$40
  • plus $161 from 7 others

What the payments were for

  • Food & beverage$722100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$722 in reported general payments places this provider in the 60th percentile of 1,852 physician assistant providers in South Carolina.

See all physician assistant providers in South Carolina

Medicare billing

Part B allowed, 2024
$43,143
Medicare patients
283
Services billed
1,077

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
NucalaMepolizumab15$55,332
Azelastine Hcl295$7,738
DuleraMometasone/Formoterol16$5,458
Epinephrine25$4,695
Fluticasone Propionate168$2,473
Fluticasone-SalmeterolFluticasone Propion/Salmeterol18$2,412
Ipratropium Bromide47$1,079
Montelukast Sodium38$340
Albuterol Sulfate HfaAlbuterol Sulfate16$313
Hydroxyzine Hcl21$287
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav19$234
Triamcinolone Acetonide13$69

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKNucala$60$55,33215 claims
Hikma Pharmaceuticals USAEpinephrine$18$4,69525 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,852 physician assistant providers in South Carolina.

Other physician assistant in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →